Controlling CRS-related coagulopathy improves the safety of CAR T-cell therapy for MM

ICARIA results: Treating RRMM patients with isatuximab, pomalidomide and low-dose dexamethasone

HORIZON update: Using melflufen to treat RRMM patients refractory to daratumumab and/or pomalidomide

Chemoimmunotherapy or BTK inhibition for patients with CLL

MOR208 plus lenalidomide in r-r diffuse large B-cell lymphoma

Using bioinformatics and genomics to treat AML

The changing landscape of AML

CLL14: A chemotherapy-free regimen of venetoclax plus obinutuzumab for CLL

Surveying cancer patients' mental health and financial problems

Project Pink Blue: Fighting cancer through increasing awareness, screening, advocacy and patient navigation

Use of maintenance therapy following ASCT and real world treatment patterns in multiple myeloma

Comment: Pregnancy outcomes in patients with chronic myeloid leukaemia